Jim Cramer recently discussed 25 stocks in a show about AI spending, with Eli Lilly and Company (NYSE:LLY) being one of them, known for its weight loss drugs. Cramer sees potential in a pill form for the drug, discussing comorbidities, stock benefits, and ratings action by BMO Capital.

Eli Lilly (LLY) has a promising drug in phase two trials, showing potential for 20 pounds weight loss. While LLY is seen as a good investment, some AI stocks may offer higher returns and lower risks. Consider exploring a free report on the best short-term AI stock.

For more insights, check out “30 Stocks That Should Double in 3 Years” and “11 Hidden AI Stocks to Buy Right Now.” Note: No disclosures in this article. Original source: Insider Monkey.

Read more at Yahoo Finance: Jim Cramer Discusses Key Point For Eli Lilly (LLY)’s Drugs